![Jennifer Cormier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Cormier is a former Vice President of Clinical Operations at Relmada Therapeutics, Inc., Sojournix, Inc., and PepGen Inc. She also holds an undergraduate degree from the University of Massachusetts Boston.
| Sociétés | Poste | Fin |
|---|---|---|
| PEPGEN INC. | Corporate Officer/Principal | 01/05/2023 |
Sojournix, Inc.
 Sojournix, Inc. BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Corporate Officer/Principal | - |
| RELMADA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
University of Massachusetts Boston
 University of Massachusetts Boston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relmada Therapeutics, Inc.
 Relmada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products for the treatment of depression and other central nervous system diseases | Health Technology |
Sojournix, Inc.
Sojournix, Inc. BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Health Technology |
PepGen Inc.
 PepGen Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company which develops oligonucleotide therapeutics for treatment of severe neuromuscular and neurologic diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
